DRUG REGIMENS FOR CONGESTIVE HEART FAILUREUNVERFERTH DV; MAGORIEN RD; LEIER CV et al.1980; GERIATRICS; ISSN 0016-867X; USA; DA. 1980; VOL. 35; NO 7; PP. 26-33; 6 P.; BIBL. 13 REF.Article

LONG-TERM SURVIVAL FOLLOWING CARDIAC RUPTURE WITH SUBSEQUENT DEVELOPMENT OF LEFT VENTRICULAR PSEUDOANEURYSMKOLIBASH AJ; MAGORIEN RD; BUSH CA et al.1982; CATHETERIZATION CARDIOVASC. DIAGN.; ISSN 0098-6569; USA; DA. 1982; VOL. 8; NO 4; PP. 409-417; BIBL. 34 REF.Article

LONG-TERM BENEFIT OF DOBUTAMINE IN PATIENTS WITH CONGESTIVE CARDIOMYOPATHYUNVERFERTH DV; MAGORIEN RD; LEWIS RP et al.1980; AM. HEART J.; ISSN 0002-8703; USA; DA. 1980; VOL. 100; NO 5; PP. 622-630; BIBL. 34 REF.Article

CLONIDINE IN CONGESTIVE HEART FAILURE: A VASODILATOR WITH NEGATIVE INOTROPIC EFFECTSHERMILLER JB; MAGORIEN RD; LEITHE ME et al.1983; AMERICAN (THE) JOURNAL OF CARDIOLOGY; ISSN 0002-9149; USA; DA. 1983; VOL. 51; NO 5; PP. 791-795; BIBL. 27 REF.Article

ELECTROPHYSIOLOGIC STUDIES OF PERPHENAZINE AND PROTRIPTYLINE IN A PATIENT WITH PSYCHOTROPIC DRUG-INDUCED VENTRICULAR FIBRILLATIONMAGORIEN RD; JEWELL GM; SCHAAL SF et al.1979; AMER. J. MED.; USA; DA. 1979; VOL. 67; NO 2; PP. 353-357; BIBL. 20 REF.Article

IMPROVED EXERCISE CAPACITY AND DIFFERING ARTERIAL AND VENOUS TOLERANCE DURING CHRONIC ISOSORBIDE DINITRATE THERAPY FOR CONGESTIVE HEART FAILURELEIER CV; HUSS P; MAGORIEN RD et al.1983; CIRCULATION; ISSN 0009-7322; USA; DA. 1983; VOL. 67; NO 4; PP. 817-822; BIBL. 21 REF.Article

HEMODYNAMIC EFFECTS OF VASODILATOR THERAPY IN SEVERE LEFT HEART FAILURE COMBINED WITH LARGE ATRIAL SEPTAL DEFECTSKOLIBASH AJ; MAGORIEN RD; ROBINSON JL et al.1982; AM. J. MED.; ISSN 0002-9343; USA; DA. 1982; VOL. 73; NO 3; PP. 439-444; BIBL. 36 REF.Article

HUMAN MYOCARDIAL MITOCHONDRIA: SIZE DIFFERENCES IN PARTS OF THE CELLUNVERFERTH DV; LEIER CV; BRIERLEY GP et al.1981; EXP. MOL. PATHOL.; ISSN 0014-4800; USA; DA. 1981; VOL. 35; NO 2; PP. 184-188; BIBL. 13 REF.Article

THE EFFECT OF FIRST-DOSE DOXORUBICIN ON THE CYCLIC NUCLEOTIDE LEVELS OF THE HUMAN MYOCARDIUMUNVERFERTH DV; FERTEL RH; TALLEY RL et al.1981; TOXICOL. APPL. PHARMACOL.; ISSN 0041-008X; USA; DA. 1981; VOL. 60; NO 1; PP. 151-154; BIBL. 23 REF.Article

REPRODUCIBILITY OF ECHOCARDIOGRAPHY IN CHRONIC CONGESTIVE HEART FAILUREUNVERFERTH DV; LEWIS RP; LEIER CV et al.1980; J.C.U. J. CLIN. ULTRASOUND.; ISSN 0091-2751; USA; DA. 1980; VOL. 8; NO 6; PP. 479-482; BIBL. 13 REF.Article

INTERATRIAL CONDUCTION (ACTIVATION) TIMESLEIER CV; JEWELL GM; MAGORIEN RD et al.1979; AMER. J. CARDIOL.; USA; DA. 1979; VOL. 44; NO 3; PP. 442-446; BIBL. 19 REF.Article

DOXORUBICIN CARDIOTOXICITYUNVERFERTH DV; MAGORIEN RD; LEIER CV et al.1982; CANCER TREAT. REV.; ISSN 0305-7372; GBR; DA. 1982; VOL. 9; NO 2; PP. 149-164; BIBL. 177 REF.Article

AUTONOMIC TONE OF PATIENTS DURING AN ELECTROPHYSIOLOGICAL CATHETERIZATION. THE ROLE OF AUTONOMIC INFLUENCES ON THE REPRODUCIBILITY OF SINUS NODE FUNCTION STUDIESJEWELL GM; MAGORIEN RD; SCHAAL SF et al.1980; AMER. HEART J.; USA; DA. 1980; VOL. 99; NO 1; PP. 51-57; BIBL. 24 REF.Article

THE EFFECT OF VASODILATOR THERAPY ON SYSTOLIC AND DIASTOLIC TIME INTERVALS IN CONGESTIVE HEART FAILURELEIER CV; MAGORIEN RD; BOUDOULAS H et al.1982; CHEST; ISSN 0012-3692; USA; DA. 1982; VOL. 81; NO 6; PP. 723-729; BIBL. 14 REF.Article

ASSESSMENT OF LEFT VENTRICULAR PRESSURE-VOLUME RELATIONS USING GATED RADIONUCLIDE ANGIOGRAPHY, ECHOCARDIOGRAPHY, AND MICROMANOMETER PRESSURE RECORDINGS. A NEW METHOD FOR SERIAL MEASUREMENTS OF SYSTOLIC AND DIASTOLIC FUNCTION IN MANMAGORIEN DJ; SHAFFER P; BUSH CA et al.1983; CIRCULATION; ISSN 0009-7322; USA; DA. 1983; VOL. 67; NO 4; PP. 844-853; BIBL. 13 REF.Article

VASODILATORS AND PROSTAGLANDIN INHIBITORS IN PRIMARY PULMONARY HYPERTENSIONHERMILLER JB; BAMBACH D; THOMPSON MJ et al.1982; ANN. INTERN. MED.; ISSN 0003-4819; USA; DA. 1982; VOL. 97; NO 4; PP. 480-489; BIBL. 37 REF.Article

BIOCHEMICAL AND HISTOLOGIC CORRELATES OF VENTRICULAR END-DIASTOLIC PRESSUREUNVERFERTH DV; MAGORIEN RD; KOLIBASH AJ et al.1981; INT. J. CARDIOL.; NLD; DA. 1981; VOL. 1; NO 2; PP. 133-142; BIBL. 36 REF.Article

POSITIVE INOTROPIE EFFECTS OF HYDRALAZINE IN HUMAN SUBJECTS: COMPARISON WITH PRAZOSIN IN THE SETTING OF CONGESTIVE HEART FAILURELEIER CV; DESCH CE; MAGORIEN RD et al.1980; AM. J. CARDIOL.; ISSN 0002-9149; USA; DA. 1980; VOL. 46; NO 6; PP. 1039-1044; BIBL. 18 REF.Article

DEVELOPMENT OF PHARMACODYNAMIC TOLERANCE TO PRAZOSIN IN CONGESTIVE HEART FAILUREDESCH CE; MAGORIEN RD; TRIFFON DW et al.1979; AMER. J. CARDIOL.; USA; DA. 1979; VOL. 44; NO 6; PP. 1178-1182; BIBL. 11 REF.Article

THE HEMODYNAMIC AND METABOLIC ADVANTAGES GAINED BY A THREE-DAY INFUSION OF DOBUTAMINE IN PATIENTS WITH CONGESTIVE CARDIOMYOPATHYUNVERFERTH DV; MAGORIEN RD; ALTSCHULD R et al.1983; AMERICAN HEART JOURNAL; ISSN 0002-8703; USA; DA. 1983; VOL. 106; NO 1; PART. 1; PP. 29-34; BIBL. 26 REF.Article

PRAZOSIN AND HYDRALAZINE IN CONGESTIVE HEART FAILUREMAGORIEN RD; TRIFFON DW; DESCH CE et al.1981; ANN. INTERN. MED.; ISSN 0003-4819; USA; DA. 1981; VOL. 95; NO 1; PP. 5-13; BIBL. 51 REF.Article